Among them, FOXO3 is widely expressed and highly correlated with a series of malignant tumors such as breast cancer, prostate cancer (PCa) and acute myeloid leukemia (AML; Du et al., 2017a; Zhou et al., 2019; Kong et al., 2020). Here, FOXO3 is linked to posterior cortical atrophy.